Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography

Investigative Radiology

Volumn 38, Issue 1, 2003, Pages 27-33

  Herborn, Christoph U ^a   Lauenstein, Thomas C ^a   Ruehm, Stefan G ^a   Bosk, Silke ^a   Debatin, Jörg F ^a   Goyen, Mathias ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Comparative studies; Gadobutrol; Gd BOPTA; Gd DTPA; MRA

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOVIST 1.0; MULTI HANCE; SODIUM CHLORIDE;

ADULT; ARTICLE; COMPARATIVE STUDY; FLOW RATE; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PELVIS ANGIOGRAPHY; PRIORITY JOURNAL;

EID: 0037231108     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200301000-00004     Document Type: Article

References (27)

1. Prince MR, Yucel EK, Kaufman JA, et al. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 1993;3:877-881.
2. Meaney JF, Weg JG, Chenevert TL, et al. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997;336:1422-1427.
3. Krinsky GA, Rofsky NM, DeCorato DR, et al. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997;202:183-193.
4. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
5. Prince MR, Schoenberg SO, Ward JS, et al. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997;205:128-136.
6. Meaney JF, Prince MR, Nostrant TT, et al. Gadolinium-enhanced MR. angiography of visceral arteries in patients with suspected chronic mesenteric ischemia. J Magn Reson Imaging 1997;7:171-176.
7. Ho KY, Leiner T, de Haan MW, et al. Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 1998;206:683-692.
8. Snidow JJ, Aisen AM, Harris VJ. et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995;196:371-378.
9. Hany TF, Debatin JF, Leung DA, et al. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357-362.
10. Schmitz SA, Albrecht T, Wolf KJ. MR angiography with superparamagnetic iron oxide: feasibility study. Radiology 1999;213:603-607.
11. Knollmann FD, Bock JC, Rautenberg K, et al. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation. Invest Radiol 1998;33:637-643.
12. Dong Q, Hurst DR, Weinmann HJ, et al. Magnetic resonance angiography with gadomer-17. An animal study original investigation. Invest Radiol 1998;33:699-708.
13. Port M, Corot C, Rousseaux O, et al. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. MAGMA 2001;12:121-127.
14. Parmelee DJ, Walovitch RC, Ouellet HS, et al. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997;32:741-747.
15. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
16. Staks T, Schuhmann-Giampieri G, Frenzel T, et al. Pharmacokinetics dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 1994;29:709-715.
17. Goyen M, Lauenstein TC, Herborn CU, et al. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): Dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 2001;14:602-607.
18. Benner T, Reimer P, Erb G, et al. Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study. J Magn Reson Imaging 2000;12:371-380.
19. Schoenberg SO, Knopp MV, Prince MR, et al. Arterial-phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection: original investigation. Invest Radiol 1998;33:506-514.
20. New, developments in magnetic resonance contrast media. A global perspective on Gadoteridol. Symposium proceedings. San Francisco, August 16, 1991. Invest Radiol 1992;27(Suppl 1):S1-S63.
21. Reference deleted in proof.
22. Grist TM. MRA of the abdominal aorta and lower extremities. J Magn Resort Imaging 2000 Jan;11:32-43.
23. Goyen M, Herborn CU, Lauenstein TC, et al. Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole body 3D MR angiography. Invest Radiol 2002;37:263-268.
24. Kreitner KF, Kalden P, Neufang A, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR 2000;174:171-179.
25. Ruehm SG, Hany TF, Pfammatter T, et al. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR 2000;174:1127-1135.
26. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001;357:1086-1091.
27. Goyen M, Quick HH, Debatin JF, et al. Whole-body three-dimensional MR angiography using a rolling table platform: Initial clinical experience. Radiology 2002;224:270-277.